Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed/Refractory Acute Myeloid Leukemia(AML)

Clinical trial condition

Relapsed/Refractory Acute Myeloid Leukemia(AML)

Explore clinical trials studying Relapsed/Refractory Acute Myeloid Leukemia(AML). Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed/Refractory Acute Myeloid Leukemia(AML) trial results

Not Yet Recruiting

A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia

NCT07441980

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Institute of Hematology & Blood Diseases Hospital, China Tianjin, China

View Trial Details

Not Yet Recruiting

A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia

NCT07233018

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.

NCT06786299

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: No. 79, Qingchun Road, Hangzhou City, Zhejiang Province. Hangzhou, Zhejiang, China

View Trial Details